Skip to content
All Brands

Par Health USA

8 recalls on record · Last recall: Oct 13, 2026

Read the history in context

Records, not a safety rating.

Recall counts do not account for sales volume, exposure or differences in reporting. Agency records can overlap. A low count does not establish that a brand or product is safe.

View source coverage →

Severity Breakdown

Class I — Serious
2
Class II — Moderate
2
Class III — Low Risk
0
Unclassified
4

Categories

MEDICATION

Recall Timeline

FDAOct 13, 2026

Par Health USA — Particulate matter: potential for the presence of particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA, Malvern, PA 19355/ Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-182-01. Quantity: N/A Particulate matter: potential for the presence of particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution. Codes: Lot #: 83449, Exp Date: 10/2026; 82682, Exp Date: 11/2026; 86714, 87302, 87560, Exp Date: 02/2027; 87753, 88401, Exp Date: 03/2027; 88614, 88836, Exp Date: 04/2027; 90220, Exp Date: 05/2027; 91216, 91219, Exp Date: 06/2027; 92004, 92006, Exp Date: 07/2027; 92009, 92596, 92782, 93107, 93329, Exp Date: 08/2027; 93890, Exp Date: 09/2027.

FDAOct 13, 2026

Par Health USA — Particulate matter: potential for the presence of particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA, Malvern, PA 19355/ Distributed by: Par Pharmaceutical, Cranbury, NJ 08512, NDC 42023-182-89. Quantity: N/A Particulate matter: potential for the presence of particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution. Codes: Lot #: 84193, Exp Date: 10/2026; 92880, Exp Date: 08/2027.

Class IFDAOct 13, 2026

Par Health USA — Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA, Malvern,PA 19355/Argatroban Injection, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-182-01. Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

Class IFDAOct 13, 2026

Par Health USA — Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA, Malvern,PA 19355/ Argatroban Injection, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Distributed by: Par Pharmaceutical, Cranbury, NJ 08512, NDC 42023-182-89. Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

FDAOct 8, 2026

Par Health USA — Presence of Particulate Matter

Brevital Sodium (methohexital sodium), 500 mg/vial, Rx only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC: 42023-105-01. Quantity: 20,567 vials Presence of Particulate Matter Codes: Lot: 86930, Exp. 02/2028; 88623, Exp. 04/2028.

FDASep 21, 2026

Par Health USA — Presence of Particulate Matter: the particulate was identified as cellulose or stopper material

Dexmedetomidine HCL in 0.9% Sodium Chloride Injection, 400 mcg/100 mL (4mcg/mL), Rx Only, 10x100 mL Single-Dose Vials per carton, Manufactured for: Endo USA, Malvern, PA 19355, Carton: NDC 42023-187-10. Vial NDC: 42023-187-01 Quantity: 773 10x100ml vials per carton Presence of Particulate Matter: the particulate was identified as cellulose or stopper material Codes: Lot #: 87558, Exp: 02/28/2027; 88802, Exp: 04/30/2027.

Class IIFDASep 8, 2026

Par Health USA — Crystallization

Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05 Crystallization

Class IIFDAJun 12, 2026

Par Health USA — Crystallization; identified as Buprenorphine free base

Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355, NDC 42023-179-05 Crystallization; identified as Buprenorphine free base

Track Par Health USA recalls automatically

Get an alert when a matching Par Health USA recall turns up.

Start Free Trial